Integra LifeSciences Holdings Corporation
IART · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $402,062 | $415,605 | $382,653 | $442,646 |
| % Growth | -3.3% | 8.6% | -13.6% | – |
| Cost of Goods Sold | $175,954 | $206,273 | $188,221 | $193,574 |
| Gross Profit | $226,108 | $209,332 | $194,432 | $249,072 |
| % Margin | 56.2% | 50.4% | 50.8% | 56.3% |
| R&D Expenses | $22,456 | $26,997 | $24,728 | $31,210 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $169,046 | $179,890 | $181,497 | $178,520 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$5,685 | $515,119 | $3,704 | $3,715 |
| Operating Expenses | $185,817 | $722,006 | $209,929 | $213,445 |
| Operating Income | $40,291 | -$512,674 | -$15,497 | $35,627 |
| % Margin | 10% | -123.4% | -4% | 8% |
| Other Income/Exp. Net | -$47,115 | -$18,278 | -$14,539 | -$13,086 |
| Pre-Tax Income | -$6,824 | -$530,952 | -$30,036 | $22,541 |
| Tax Expense | -$1,420 | -$46,879 | -$4,743 | $3,106 |
| Net Income | -$5,404 | -$484,073 | -$25,293 | $19,435 |
| % Margin | -1.3% | -116.5% | -6.6% | 4.4% |
| EPS | -0.07 | -6.33 | -0.33 | 0.25 |
| % Growth | 98.9% | -1,818.2% | -232% | – |
| EPS Diluted | -0.07 | -6.33 | -0.33 | 0.25 |
| Weighted Avg Shares Out | 76,753 | 76,463 | 76,463 | 77,010 |
| Weighted Avg Shares Out Dil | 76,753 | 76,463 | 76,463 | 77,010 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,982 | $4,710 | $1,787 | $4,893 |
| Interest Expense | $22,725 | $21,042 | $20,241 | $18,984 |
| Depreciation & Amortization | $38,162 | $37,692 | $37,188 | $37,492 |
| EBITDA | $54,063 | -$472,218 | $25,967 | $79,114 |
| % Margin | 13.4% | -113.6% | 6.8% | 17.9% |